@inproceedings{inproceedings, title = {{171鈥匬revalence of a nice-defined indication for inclisiran in a real-world trans-pandemic acute coronary syndrome cohort}}, publisher = {{BMJ Publishing Group Ltd and British Cardiovascular Society}}, url = {{http://dx.doi.org/10.1136/heartjnl-2022-bcs.171 }}, year = {{2022}}, month = {{6}}, author = {{Shaji N and Elamin N and Nelson T and Varian F and Storey R and Parker W}}, doi = {{10.1136/heartjnl-2022-bcs.171}}, journal = {{Stable IHD/Prevention/Hypertension/Lipids}}, note = {{Accessed on 2025/06/20}}}